Join Our Mailing List:
 
Follow Us:
Shop Contact Us
You have 0  Item in Cart | View Cart
310-841-2600
Featured Events
Thursday, September 04
Pop-Up Night of Fashion
Join us at the Malibu Country Mart for a Runway Fashion Show featuring Morgane Le Fay & John Varvatos ... More
Sunday, September 28
5th Annual STOP CANCER 5|10K Run|Walk
On your mark, get set, go! Be part of the 5th Annual 5|10K Run|Walk ... More
Sunday, November 23
STOP CANCER Annual Gala Evening
Celebrate the mission of STOP CANCER and join us in honoring two ... More
View All Events
Ching-Cheng Chen, Ph.D.
Research performed at: City of Hope Comprehensive Cancer Center
Specialty/Research Area: Stem Cell, Leukemia
Award Year: 2013

Career Summary: Dr. Chen is Assistant Professor, Division of hematopoietic stem cell and leukemia Research, Beckman Research Institute of City of Hope (Duarte, CA) He received his Ph.D. in immunology in 2001 from the University of Alabama at Birmingham, followed by a two year postdoctoral fellowship there (2001 -2003). From 2003 – 2009, he undertook a second postdoctoral fellowship at the Stanford University (Stanford, CA). He was later promoted to Instructor (2009) at Stanford University before he joined his current position (2010 - ). In addition to his award from STOP CANCER, he is the recipient of the NIH Pathway to Independence (PI) Award (K99/R00).

 

Year STOP CANCER Award was received: 2013 RCDA
 

Description of Research Performed: Dr. Chen’s research group is investigating the factors in the bone marrow microenvironment that help leukemia cells evade chemotherapy and the mechanisms used by leukemia cells to modulate the bone marrow microenvironment, such that they are supported in lieu of normal blood progenitor cells.

 

Results of Research: Dr. Chen’s group has established mouse models and cell culture systems to study the interactions between leukemia cells and the bone marrow microenvironment. The research will foster an improved understanding of cellular and molecular properties of the bone marrow microenvironment and how those factors promote leukemia initiation and progression. Results from the studies should suggest novel therapeutic strategies with which to target the malignant niche in order to provide better treatment options for patients with leukemia and other bone marrow metastases.

STOP CANCER is committed to funding the most promising and innovative scientists in their early research of all forms of cancer prevention, treatment, cures and subsequent clinical applications. STOP CANCER works primarily with local National Cancer Institute-designated Comprehensive Cancer Centers and other qualified institutions in the United States to carry out its mission.

Copyright © 2014 STOP CANCER. All Rights Reserved. | Privacy Policy